These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16729482)

  • 1. [Myocardial necrosis and cardiogenic shock with normal coronaries: cardiotoxicity due to 5-FU or catecholamine cardiomyopathy].
    Rodríguez Roldán JM; Lara Alvarez MA; López Martínez J; Díaz Abad R; Caballero Campo M; Del Nogal Sáez F
    Med Intensiva; 2006 Apr; 30(3):123-4. PubMed ID: 16729482
    [No Abstract]   [Full Text] [Related]  

  • 2. Various Manifestations of 5-Fluorouracil Cardiotoxicity: A Multicenter Case Series and Review of Literature.
    Allison JD; Tanavin T; Yang Y; Birnbaum G; Khalid U
    Cardiovasc Toxicol; 2020 Aug; 20(4):437-442. PubMed ID: 31925673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report.
    Akhtar SS; Wani BA; Bano ZA; Salim KP; Handoo FA
    Tumori; 1996; 82(5):505-7. PubMed ID: 9063536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible cardiogenic shock following 5-fluorouracil infusion.
    Ferté C; Gomez Roca C; Loriot Y; Bahleda R; Moldovan C; Cohen A; Izzedine H; Soria JC; Ederhy S
    Invest New Drugs; 2010 Aug; 28(4):531-3. PubMed ID: 19499187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiotoxicity of 5-fluorouracil: ischemia or myocardial toxicity?].
    López Medrano F; Sánchez Muñoz A; Sánchez Sánchez V; Costa Pérez-Herrero JR
    Rev Clin Esp; 2001 Feb; 201(2):106-7. PubMed ID: 11345600
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reversible cardiogenic shock under 5-fluorouracil treatment].
    Bakouboula B; Morel O; Douchet MP; Chauvin M
    Ann Cardiol Angeiol (Paris); 2005 Aug; 54(4):216-9. PubMed ID: 16104623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capecitabine caused cardiogenic shock through induction of global Takotsubo syndrome.
    Y-Hassan S; Tornvall P; Törnerud M; Henareh L
    Cardiovasc Revasc Med; 2013; 14(1):57-61. PubMed ID: 23218901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine may induce coronary artery vasospasm.
    Tsiamis E; Synetos A; Stefanadis C
    Hellenic J Cardiol; 2012; 53(4):320-3. PubMed ID: 22796820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angina induced by 5-fluorouracil infusion in a patient with normal coronaries.
    Tajik R; Saadat H; Taherkhani M; Movahed MR
    Am Heart Hosp J; 2010; 8(2):E111-2. PubMed ID: 21928176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiotoxicity of 5-fluorouracil].
    Teixeira L; Barry S; Debourdeau P; Cohen A; Tournigand C
    Bull Cancer; 2004 Nov; 91 Suppl 3():154-8. PubMed ID: 15899622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy.
    Endo A; Yoshida Y; Nakashima R; Takahashi N; Tanabe K
    Int Heart J; 2013; 54(6):417-20. PubMed ID: 24309454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of cardiogenic shock caused by capecitabine treatment.
    To AC; Looi KL; Damianovich D; Taylor GB; Sidebotham D; White HD
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):725-9. PubMed ID: 18813211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk.
    Lestuzzi C; Vaccher E; Talamini R; Lleshi A; Meneguzzo N; Viel E; Scalone S; Tartuferi L; Buonadonna A; Ejiofor L; Schmoll HJ
    Ann Oncol; 2014 May; 25(5):1059-64. PubMed ID: 24558023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for routine monitoring of cardiac function in patients receiving 5-fluorouracil infusion.
    Francis N
    Clin J Oncol Nurs; 2014 Jun; 18(3):360-2. PubMed ID: 24867118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
    Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
    Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary artery stenting in the treatment of 5-fluorouracil-induced unstable angina].
    Grześk G; Orzałkiewicz Z; Polak G; Przybył R; Nartowicz E; Szadujkis-Szadurski L; Grabczewska Z
    Przegl Lek; 2003; 60(1):46-8. PubMed ID: 12884648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?
    Steger F; Hautmann MG; Kölbl O
    Radiat Oncol; 2012 Dec; 7():212. PubMed ID: 23241239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.
    Akpek G; Hartshorn KL
    Cancer Chemother Pharmacol; 1999; 43(2):157-61. PubMed ID: 9923822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of myocardial ischaemia induced by 5-fluorouracil.
    Görgülü S; Oğuz E; Zor A; Zor U; Gürdoğan M; Tezel T
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):259-61. PubMed ID: 12223336
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of extracorporeal membrane oxygenation for mechanical circulatory support in a patient with 5-fluorouracil induced acute heart failure.
    Rateesh S; Shekar K; Naidoo R; Mittal D; Bhaskar B
    Circ Heart Fail; 2015 Mar; 8(2):381-3. PubMed ID: 25783948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.